Barrière, an emerging leader in the wearable supplement sector, is significantly scaling its retail operations by entering 1,700 Walmart locations. This strategic expansion introduces a pioneering lactose intolerance patch—the first of its kind available to the public—alongside a new motion sickness solution. This development represents a major growth milestone for the brand as it attempts to modernize the delivery methods of daily vitamins and wellness aids.

The company is currently undergoing a period of rapid scaling, with plans to grow its retail footprint from roughly 600 stores in mid-2025 to more than 6,000 by the middle of 2026. This aggressive growth follows a massive 3,000% increase in wholesale volume throughout 2025. With a current valuation of $19 million, the company is projecting annual revenues to hit $10 million by 2026.

At the core of the brand’s success is its proprietary transdermal technology, which serves as an alternative to traditional oral supplements. By utilizing body heat and ultrasmall vitamin particles, the patches deliver ingredients directly into the bloodstream for up to 12 hours. Founded by Cleo Davis-Urman, the company aims to solve common issues related to pill absorption and convenience. The patches are designed with an aesthetic focus, featuring floral and jewel-toned patterns that prioritize style over the clinical appearance of standard medical adhesives.

To differentiate itself within the $60 billion supplement industry, Barrière is prioritizing consumer trust through manufacturing transparency. While the U.S. supplement market remains largely unregulated, the company produces its goods in the United Kingdom to ensure compliance with more rigorous international standards. This commitment to quality is intended to attract health-conscious consumers seeking reliable, high-performance wellness solutions that integrate easily into a modern lifestyle.

Key Takeaways

• Barrière is expanding into 1,700 Walmart stores, with plans to reach 6,000 retail locations by mid-2026.
• The company is launching the market's first transdermal lactose intolerance patch, utilizing body heat for 12-hour ingredient delivery.
• To ensure product quality and safety, the brand manufactures its supplements in the UK, bypassing the looser regulatory environment of the U.S. supplement market.

Editor’s Analysis & Impact

Barrière’s rapid expansion signals a broader shift in the $60 billion supplement industry toward ‘wearable wellness.’ By moving away from the pill-based model, the company is addressing ‘pill fatigue’ and absorption efficiency, which are significant pain points for consumers. The decision to manufacture in the UK is a calculated move to build brand equity and trust in an industry often criticized for lack of oversight. If the company successfully maintains its growth trajectory, it could force legacy supplement brands to innovate their delivery mechanisms or risk losing market share to more lifestyle-oriented, tech-forward competitors. The focus on aesthetic, discreet design also suggests that wellness products are increasingly being marketed as fashion-adjacent accessories rather than purely medicinal items, a trend likely to continue in the consumer health space.

Frequently Asked Questions

Q: How do Barrière patches deliver vitamins into the body?
A: The patches use transdermal technology that relies on the wearer's body heat to deliver ultrasmall vitamin particles directly into the bloodstream over a 12-hour period.

Q: Why does Barrière manufacture its products in the United Kingdom?
A: The company chooses to manufacture in the UK to adhere to stricter regulatory standards, providing a level of quality assurance that is often lacking in the largely unregulated U.S. supplement market.